Zenas Biopharma (usa), Llc

This study is testing whether a drug called obexelimab can prevent symptom flare-ups in people with IgG4-related disease, an autoimmune condition that causes inflammation and organ damage. Participants receive either the drug or a placebo injection while tapering off steroids, an…

This study is testing whether a new injectable medication called obexelimab can help control relapsing multiple sclerosis. It will involve 93 people with MS who will receive either the drug or a placebo for 12 weeks, followed by a longer period where everyone gets the drug. Resea…